Harvard Scientific (HVSF)Hot$$- male impotency medicine Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Afaq Sarwar who wrote (3298)	2/22/1998 6:53:00 PM
From: Afaq Sarwar	Read Replies (1) of 3906

All, More information on HVSFD patent, provides all claims in detail: patent.womplex.ibm.com Also, I saw the following post on VVUS thread: Message 3491607 -------------------------------------------------------- To: Tunica Albuginea (5564 ) From: Cacaito Friday, Feb 20 1998 10:34PM EST Reply # of 5606 HVSFD "patent" claims an "intrameatal" delivery, they are calling the opening of the urethra (the meatus) a different anatomic part of the penis,at least different enough to justify their "patent". A different word to keep selling their worthless stock. This will not hold in any court, one only need a dictionary to see it. Meatus urinarius: opening part of the urethra. So if it is delivered intrameatally, it is the same as delivered intraurethrally and cover by Vivus patent. -------------------------------------------------------- After doing some research, I offered the following responses to this post: Message 3499632 Message 3499821 Message 3500423 Message 3500788 Afaq Sarwar

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next